farnesol and as 1411
farnesol has been researched along with as 1411 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Juster, D; Kloog, Y; Pinkas-Kramarski, R; Schokoroy, S | 1 |
| Goldshmit, Y; Kloog, Y; Pinkas-Kramarski, R; Trangle, SS | 1 |
Other Studies
2 other study(ies) available for farnesol and as 1411
| Article | Year |
|---|---|
Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death.
Topics: Animals; Aptamers, Nucleotide; Carcinogenesis; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Humans; Immunoblotting; Immunohistochemistry; Mice; Mice, Nude; Microscopy, Fluorescence; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; ras Proteins; RNA-Binding Proteins; Salicylates | 2013 |
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aptamers, Nucleotide; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Glioblastoma; Humans; Mice, Nude; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; Phosphorylation; ras Proteins; Receptor Cross-Talk; RNA-Binding Proteins; Salicylates; Signal Transduction; Time Factors; Tumor Burden | 2014 |